Linked e-resources

Details

Phenomenology of Levodopa-Induced Dyskinesia
Dyskinesia Rating Scales in Parkinson's Disease
Epidemiology of Levodopa-Induced Dyskinesia
Risk Factors for Levodopa-Induced Dyskinesia
Pharmacological Treatment Options for Levodopa-Induced Dyskinesia
Surgical Options for Levodopa-Induced Dyskinesia in Parkinson?s Disease
Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia
Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia
Pharmacological Properties of Levodopa
Dopamine Receptors and LID
The Serotonergic System In Levodopa-Induced Dyskinesia
The Opioid System in Levodopa-Induced Dyskinesia
Glutamate Receptors and Levodopa-Induced Dyskinesia
Cannabinoids and Levodopa-Induced Dyskinesia
The Role of the Noradrenergic System and its Receptors In Levodopa-Induced Dyskinesia
Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia
New Clinical Trials for Levodopa-Induced Dyskinesia
Preclinical Models of Levodopa-Induced Dyskinesia
Final Thoughts: Summary and Future Therapeutic Strategies in LID.

Browse Subjects

Show more subjects...

Statistics

from
to
Export